Explore more of the ways Rutgers research is shaping the future .
What are GLP-1 weight loss medications
As estrogen levels embark on their downward rollercoaster throughout perimenopause, muscle mass maintenance becomes more and more challenging
What to Expect in Months 4-6 Minimal side effects: 85%+ patients report little to no symptoms Fastest weight loss period: Average loss 15-18% by week 24 Appetite suppression as primary effect: Not unpleasant, just not hungry Metabolic improvements: Blood pressure drops, triglycerides down 28%, A1C down 1.8% in diabetics Increased confidence and motivation: Visible results, compliments from others, clothes fitting differently Data from Diabetes Care journal shows this acceleration phase is when cardiovascular benefits become measurable, blood pressure improvements, lipid improvements, reduced inflammation markers
The dual mechanism gives it an edge in patients without diabetes in particular
Clinical studies have demonstrated significant weight loss outcomes in individuals using Retatrutide, particularly when combined with a balanced diet and consistent exercise routine